Other

Issuance Of Subsidiary Shares In Connection With Debt Renegotiation

Year-over-year, this metric declined by 100.0%, from $23.29M to $0.00.

Analysis

StatementCash Flow Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ4 2025May 20, 2026

How to read this metric

Signals a preference for equity-based debt restructuring to preserve cash, often seen in complex corporate structures.

Detailed definition

Non-cash issuance of equity in a subsidiary to settle or renegotiate debt obligations. This represents a strategic use o...

Peer comparison

Specific to holding companies or firms with multiple consolidated subsidiaries.

Metric ID: other_issuance_of_subsidiary_shares_in_connection_with_d_5591b3

Historical Data

16 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$11.65M-$23.29M$0.00$23.29M$0.00$0.00$0.00$0.00
QoQ Change-300.0%+100.0%-100.0%
YoY Change-100.0%+100.0%-100.0%
Range-$23.29M$23.29M
Avg YoY Growth-33.3%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Roivant Sciences's issuance of subsidiary shares in connection with debt renegotiation?
Roivant Sciences (ROIV) reported issuance of subsidiary shares in connection with debt renegotiation of $0.00 in Q1 2026.
How has Roivant Sciences's issuance of subsidiary shares in connection with debt renegotiation changed year-over-year?
Roivant Sciences's issuance of subsidiary shares in connection with debt renegotiation decreased by 100.0% year-over-year, from $23.29M to $0.00.
What does issuance of subsidiary shares in connection with debt renegotiation mean?
Using subsidiary stock to pay off or restructure debt.